Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 4, 2005, Pages 1021-1029

  Brunner, Thomas B ^a   Merkel, Susanne ^a   Grabenbauer, Gerhard G ^a   Meyer, Thomas ^a   Baum, Ulrich ^a   Papadopoulos, Thomas ^a   Sauer, Rolf ^a   Hohenberger, Werner ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Conformal radiotherapy; Lymphatic metastasis; Pancreatic carcinoma

Indexed keywords

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; HISTOLOGY; PATHOLOGY; TOXICITY;

CHEMORADIATION; LYMPHATIC AREAS; NODAL METASTASIS; PANCREATIC HEAD;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; FEMALE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PRACTICE GUIDELINES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 21244487364     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.12.018     Document Type: Article

References (34)

1. National Cancer Institute Annual cancer statistics review 1973-1988 1991 Department of Health and Human Services Bethesda, MD NIH Publication No. 91-2789.
2. J.F. Griffin, S.R. Smalley, W. Jewell Patterns of failure after curative resection of pancreatic carcinoma Cancer 66 1990 56 61
3. C.J. McGinn, M.M. Zalupski Combined-modality therapy in pancreatic cancer Current status and future directions Cancer J 7 2001 338 348
4. H. Snady, H. Bruckner, A. Cooperman Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma An outcomes trial Cancer 89 2000 314 327
5. J.P. Neoptolemos, D.D. Stocken, H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
6. C.H. Crane, R.A. Wolff, J.L. Abbruzzese Combining gemcitabine with radiation in pancreatic cancer Understanding important variables influencing the therapeutic index Semin Oncol 28 2001 25 33
7. A.G. Morganti, L. Trodella, V. Valentini Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma a phase I study Onkologie 26 2003 325 329
8. T.B. Brunner, G.G. Grabenbauer, P. Klein Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 55 2003 144 153
9. R. Wilkowski, M. Thoma, V. Heinemann Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer - feasible and effective Strahlenther Onkol 2003 78 86
10. Y.R. Bai, G.H. Wu, W.J. Guo Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer Results of feasibility study World J Gastroenterol 9 2003 2561 2564
11. A.C. Koong, Q.T. Le, A. Ho Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 58 2004 1017 1021
12. S.R. Smalley, L. Gunderson, J. Tepper Gastric surgical adjuvant radiotherapy consensus report rationale and treatment implementation Int J Radiat Oncol Biol Phys 52 2002 283 293
13. O. Ishikawa, H. Ohhigashi, Y. Sasaki Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head Ann Surg 208 1988 215 220
14. Y. Kawarada, B.C. Das, T. Naganuma Surgical treatment of pancreatic cancer Does extended lymphadenectomy provide a better outcome? J Hepatobiliary Pancreat Surg 8 2001 224 229
15. J.H. Muler, C.J. McGinn, D. Normolle Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer J Clin Oncol 22 2004 238 243
16. N. Ando, A. Nakao, S. Nomoto Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma Pancreas 15 1997 374 378
17. M. Niedergethmann, M. Rexin, R. Hildenbrand Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma Am J Surg Pathol 26 2002 1578 1587
18. T.A. Sohn, C.J. Yeo, J.L. Cameron Resected adenocarcinoma of the pancreas - 616 patients results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
19. A. Richter, M. Niedergethmann, J.W. Sturm Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head 25-year experience World J Surg 27 2003 324 329
20. T. Yoshida, T. Matsumoto, A. Sasaki Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma Am J Surg 187 2004 736 740
21. M. Kayahara, T. Nagakawa, T. Ohta Analysis of paraaortic lymph node involvement in pancreatic carcinoma A significant indication for surgery? Cancer 85 1999 583 590
22. T. Nagakawa, H. Kobayashi, K. Ueno Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas Cancer 73 1994 1155 1162
23. L.H. Sobin, C. Wittekind TNM classification of malignant tumors 6th ed. 2002 Wiley-Liss Hoboken, NJ
24. S. Merkel, U. Mansmann, T. Meyer Confusion by frequent changes in staging of exocrine pancreatic carcinoma Pancreas 29 2004 171 178
25. S. Pedrazzoli, H.G. Beger, H. Obertop A surgical and pathological based classification of resective treatment of pancreatic cancer Summary of an international workshop on surgical procedures in pancreatic cancer Dig Surg 16 1999 337 345
26. J.A. Purdy Defining our goals Volume and dose specification for 3-D conformal radiation therapy Front Radiat Ther Oncol 29 1996 24 30
27. A. Stojadinovic, A. Brooks, A. Hoos An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma J Am Coll Surg 196 2003 954 964
28. C.G. Willett, J.W. Clark Update on combined-modality treatment options for pancreatic cancer Oncology (Huntingt) 17 2003 29 36
29. B. Bussels, L. Goethals, M. Feron Respiration-induced movement of the upper abdominal organs A pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer Radiother Oncol 68 2003 69 74
30. A.C. Berger, J.C. Watson, E.A. Ross The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma Am Surg 70 2004 235 240
31. G. Benassai, M. Mastrorilli, G. Quarto Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas J Surg Oncol 73 2000 212 218
32. J.P. Hoffman, S. Lipsitz, T. Pisansky Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas an Eastern Cooperative Oncology Group Study J Clin Oncol 16 1998 317 323
33. H. Deki, T. Sato An anatomic study of the peripancreatic lymphatics Surg Radiol Anat 10 1988 121 135
34. Japanese Pancreatic Society General rules for surgical and pathological studies on cancer of the pancreas 4th ed 1993 Kanehara Press Tokyo